MENU
ARVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Arvinas (ARVN) Ownership - Who owns Arvinas?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.31B
P/E Ratio
N/A
Total Cash
1.12B
Projected Growth
N/A
Total Debt
1.5M
Revenue
161.1M
Risk (Beta)
1.97
Dividend Yield
N/A
Total Cash/Share
16.32
Total Debt/Equity
N/A
Revenue/Share
2.33 USD as % of share price
Fundamentals
ARVN
Capitalization
1.31B
P/E Ratio
N/A
Risk (Beta)
1.97
Dividend Yield
N/A
Total Cash
1.12B
Total Cash/Share
16.32
Total Debt
1.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.33%
Revenue
161M
ROE
N/A
Book Value
586M
P/B Ratio
2.24
Cash Flow
N/A
Earnings
-4.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
4.17
Current Revenue Per Employee
230112.36
Dividends Per Share - Security
N/A
EBITDA
-350.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.73
Shares Held By Institutions
3.99B
Shares Outstanding - Current
68.7M
Total Liabilities
581M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-53.596
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapies to degrade disease-causing proteins
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com